Autor: |
BHASKARABHATLA, AJAY |
Předmět: |
|
Zdroj: |
Antitrust Law Journal; 2020, Vol. 83 Issue 1, p41-73, 33p, 1 Chart, 7 Graphs |
Abstrakt: |
In this article, the author examine how India's treatment of maximum resale price maintenance and facilitates cartelization in the pharmaceutical industry. It mentions jurisdictions featuring relatively friendlier legal treatment towards RPM can be instructive in revealing potential anticompetitive effects. It also mentions trade associations of retailers and manufacturers guide them during periods of bargaining challenges. |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|